Early stage life sciences company iBIONICS has had “a phenomenal year of growth and learning,” says CEO and co-founder Suzanne Grant.
The company, which is developing a bionic-eye system to restore vision in people with retinal degenerative diseases, has reached combined private and public funding goals of US$2.5 million and added another $1.5 million in grants; it also expects to finalize additional pre-seed financing in the next two quarters.
The firm has secured an exclusive worldwide licence for its prototype and has recently celebrated several other business and technical milestones.
OBJ360 (Sponsored)
Lanark County: One county, nine districts, limitless adventures
Enjoy unique outdoors experiences you can’t find anywhere else
What’s happening in Ottawa in 2024? Ottawa Tourism has your activity line-up covered
2024 promises to be another fun-filled year for Ottawans and visitors alike!
Ms. Grant and iBIONICS were also chosen to exhibit at the Accessibility Innovation Showcase at the Invictus Games in Toronto in September.
